Zoetis Inc. $ZTS Shares Acquired by Robertson Stephens Wealth Management LLC

Key Points

• Robertson Stephens Wealth Management LLC boosted its position in Zoetis by 790.9% in Q4, adding 14,814 shares to hold 16,687 shares worth about $2.1 million, and 92.8% of Zoetis is currently owned by institutional investors.
• Analysts maintain a consensus Hold rating with a $151.75 target, reflecting mixed views and recent price-target cuts (e.g., Piper Sandler to $135 and UBS to $130) amid a split of 7 Buy, 7 Hold and 1 Sell.
• Zoetis beat quarterly expectations (EPS $1.48 vs. $1.40; revenue $2.39B, +3%), set FY2026 guidance of $7.00–$7.10 EPS, and declared a $0.53 quarterly dividend (annual $2.12, ~1.9% yield).

Robertson Stephens Wealth Management LLC lifted its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 790.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,687 shares of the company's stock after acquiring an additional 14,814 shares during the quarter. Robertson Stephens Wealth Management LLC's holdings in Zoetis were worth $2,100,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the company. Oppenheimer & Co. Inc. increased its stake in shares of Zoetis by 15.1% during the fourth quarter. Oppenheimer & Co. Inc. now owns 104,946 shares of the company's stock worth $13,204,000 after acquiring an additional 13,764 shares during the period. Secured Retirement Advisors LLC acquired a new position in shares of Zoetis during the fourth quarter worth about $844,000. Sigma Planning Corp increased its stake in shares of Zoetis by 3.8% during the fourth quarter. Sigma Planning Corp now owns 3,401 shares of the company's stock worth $424,000 after acquiring an additional 124 shares during the period. Laurel Wealth Advisors LLC acquired a new position in shares of Zoetis during the fourth quarter worth about $50,000. Finally, Verity Asset Management Inc. boosted its holdings in Zoetis by 11.5% during the fourth quarter. Verity Asset Management Inc. now owns 2,634 shares of the company's stock worth $331,000 after buying an additional 271 shares in the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently commented on ZTS. Piper Sandler reissued a "neutral" rating and set a $135.00 price objective (down from $190.00) on shares of Zoetis in a report on Thursday, January 22nd. Leerink Partners reissued a "market perform" rating on shares of Zoetis in a report on Tuesday, March 10th. BTIG Research reissued a "buy" rating and set a $160.00 price objective on shares of Zoetis in a report on Thursday, February 26th. Citigroup began coverage on shares of Zoetis in a report on Wednesday, April 15th. They set a "buy" rating and a $145.00 price objective on the stock. Finally, UBS Group decreased their price objective on shares of Zoetis from $136.00 to $130.00 and set a "neutral" rating on the stock in a report on Tuesday, April 28th. Seven analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $151.75.

Zoetis Stock Down 0.7%

ZTS stock opened at $114.22 on Friday. Zoetis Inc. has a 52 week low of $112.97 and a 52 week high of $172.23. The company has a market cap of $48.05 billion, a P/E ratio of 18.97, a P/E/G ratio of 1.76 and a beta of 0.87. The company has a current ratio of 3.03, a quick ratio of 1.94 and a debt-to-equity ratio of 2.71. The company's 50-day moving average price is $119.93 and its 200 day moving average price is $124.67.

Zoetis (NYSE:ZTS - Get Free Report) last announced its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.08. Zoetis had a net margin of 28.24% and a return on equity of 62.02%. The company had revenue of $2.39 billion for the quarter, compared to the consensus estimate of $2.36 billion. During the same quarter in the prior year, the firm earned $1.40 earnings per share. The company's revenue for the quarter was up 3.0% compared to the same quarter last year. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, research analysts expect that Zoetis Inc. will post 7.01 earnings per share for the current fiscal year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Shareholders of record on Monday, April 20th will be issued a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.9%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis's dividend payout ratio is 35.22%.

Zoetis Company Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.